Near Infrared Spectroscopy (St02)
St02
Near Infrared Spectroscopy (NIRS) to Measure Tissue Oxygen Saturation (St02)
1 other identifier
observational
186
1 country
1
Brief Summary
The overall hypotheses of this project is that Near Infrared Spectroscopy (NIRS) can be used to identify morbidity, mortality, and resource utilization in patients with sepsis and septic shock.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2009
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 3, 2010
CompletedFirst Posted
Study publicly available on registry
February 4, 2010
CompletedOctober 29, 2024
October 1, 2024
1 year
February 3, 2010
October 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Organ Dysfunction and Severity of Illness
time 0 - 24 hrs
Secondary Outcomes (1)
Mortality
In hospital
Study Arms (3)
Shock Cohort
The SHOCK cohort will meet the American College of Chest physicians/Society of Critical Care Medicine criteria for septic shock, specifically: * 1\) Suspected infection * 2\) Any two of four criteria of systemic inflammatory response: * a. Temperature \> 100.4° or \< 96.8° F * b. Heart rate \> 90 beats/minute * c. Respiratory rate \> 20 breaths/min. or PaCO2 \< 32 mm Hg * d. WBC \>12,000 or \< 4000 cells/µL or \> 10% bands * 3\) Hypotension despite adequate fluid resuscitation: * a. SBP \< 90 mm Hg after 20cc/kg crystalloid
Sepsis cohort
The SEPSIS cohort will to meet: * 1\) Suspected infection * 2\) Any two of four criteria of systemic inflammatory response: * a. Temperature \> 100.4° or \< 96.8° F * b. Heart rate \> 90 beats/minute * c. Respiratory rate \> 20 breaths/min. or PaCO2 \< 32 mm Hg * d. WBC \>12,000 or \< 4000 cells/µL or \> 10% bands * 3\) Absence of refractory hypotension
Non-Infected controls
The third cohort will be comprised of uninfected ED control patients who met the criteria of no suspected infection, no SIRS criteria met and no evidence of hypoperfusion that are age and sex matched on a 1:1 basis with the shock cohort.
Interventions
The InSpectra StO2 Tissue Oxygenation Monitor (model 650; Hutchinson Technology, Hutchinson, MN, USA) with probes spaced at 15 mm will be utilized to obtain StO2 measurements. Following a minimum initial five-minute stabilization period, the initial StO2 will be measurement and then a Vasoocclusive Testing Procedure (VOT) will be performed using an automated tourniquet (Delfi Tourniquet System; Delfi Medical Innovations, Inc, Vancouver, BC, Canada), insufflated to 50 mmHg over the patient's SBP for a period of three minutes.
Eligibility Criteria
Patients presenting to the Emergency Department (ED) of one of three large, urban, tertiary care facilities.
You may qualify if:
- Listed on the Cohorts description.
You may not qualify if:
- Age \< 18 years
- Pregnancy
- Established "Do Not Resuscitate" orders prior to enrollment
- Primary diagnosis of:
- Acute traumatic or burn injury
- Acute cerebrovascular event
- Acute coronary syndrome
- Acute pulmonary edema
- Cardiac dysrhythmia
- Acute and active gastrointestinal bleeding
- Acute drug overdose
- Requirement for immediate surgery
- Inability to obtain written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beth Israel Deaconess Medical Centerlead
- Hutchinson Technology Inccollaborator
- Astute Medical, Inc.collaborator
- Axis Shield Diagnostics Ltdcollaborator
Study Sites (1)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Related Publications (2)
Skibsted S, Arnold R, Sherwin R, Singh S, Lundy D, Nelson T, Puskarich MA, Trzeciak S, Jones AE, Shapiro NI. The association of near infrared spectroscopy-derived StO2 measurements and biomarkers of endothelial activation in sepsis. Intern Emerg Med. 2013 Sep;8(6):529-36. doi: 10.1007/s11739-013-0973-3. Epub 2013 Jul 4.
PMID: 23824446RESULTShapiro NI, Arnold R, Sherwin R, O'Connor J, Najarro G, Singh S, Lundy D, Nelson T, Trzeciak SW, Jones AE; Emergency Medicine Shock Research Network (EMShockNet). The association of near-infrared spectroscopy-derived tissue oxygenation measurements with sepsis syndromes, organ dysfunction and mortality in emergency department patients with sepsis. Crit Care. 2011;15(5):R223. doi: 10.1186/cc10463. Epub 2011 Sep 22.
PMID: 21939529RESULT
Biospecimen
Whole blood, serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nathan I Shapiro, MD, MPH
Beth Israel Deaconess Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
February 3, 2010
First Posted
February 4, 2010
Study Start
January 1, 2009
Primary Completion
January 1, 2010
Study Completion
January 1, 2010
Last Updated
October 29, 2024
Record last verified: 2024-10